Year: 2004
Language: Arabic
This resource is also available in: الإنجليزية الفرنسية الروسية الأسبانية الصينية المبسطة
Format: Document
Also Available In: Japanese
Treating people with hemophilia with safe, regulated plasma-derived factor concentrate directly reduces the social and economic impact of this bleeding disorder on the patient as well as the amount of long-term support required from family, community, and government.
دعا الاتحاد العالمي للهيموفيليا ممثلين عن المنظمات الوطنية الأعضاء في الاتحاد والحكومات الوطنية ومقدمي الرعاية الصحية والشركاء من شركات الأدوية
Listen to this 2-hour webinar presented on April 22, 2021 to learn about global topics related to bleeding disorders. The
This illustrated schematic demonstrates the normal process of blood clotting, how it is diminished when a clotting factor is lacking,
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Polish Desmopressin (DDAVP) may
Quality data are extremely useful in advocating for better care for people with bleeding disorders. This Fact Sheet introduces the
Also Available In: Japanese Access to a comprehensive hemophilia treatment centre (HTC) is a critical component of care. This fact
